Task Force on Sudden Cardiac Death of the European Society of Cardiology.

The members of the Task Force on Sudden Death dedicate this paper to the memory of our former friend and colleague, Professor Ronald W. F. Campbell. Ronnie spent his life working in the field of sudden cardiac death; he contributed much and helped many. But his own life fell victim to this very problem, sadly illustrating its unexpected nature. With Ronnie’s memory in mind the Task Force has worked diligently to describe the extent of our expanding knowledge in this field, hoping that our small contribution might help to appease his sad and sudden death.

[1]  B. Maron.  Sudden death in young athletes. , 1980, The New England journal of medicine.

[2]  R. Levine,et al.  Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. , 2002, Journal of the American College of Cardiology.

[3]  P B Iannini,et al.  Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. , 2001, The Journal of antimicrobial chemotherapy.

[4]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[5]  S. Cobbe,et al.  Dispersion of ventricular repolarization and refractory period. , 2001, Cardiovascular research.

[6]  P. Elliott,et al.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[7]  R. Gow.  Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2001, Circulation.

[8]  A. Hallstrom,et al.  “Stable” Ventricular Tachycardia Is Not a Benign Rhythm: Insights From the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry , 2001, Circulation.

[9]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[10]  D. Corrado,et al.  Ventricular Preexcitation in Children and Young Adults: Atrial Myocarditis as a Possible Trigger of Sudden Death , 2001, Circulation.

[11]  G. Fontaine,et al.  Myocarditis as a cause of sudden death. , 2001, Circulation.

[12]  G. Breithardt,et al.  Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .

[13]  S. Priori,et al.  The Long QT Syndrome , 1997, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  B. Maron,et al.  Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort. , 2001, The American journal of cardiology.

[15]  Kenneth Egstrup,et al.  Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial , 2000, The Lancet.

[16]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[17]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[18]  F. Alla,et al.  Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.

[19]  S. Priori,et al.  Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families , 2000, Circulation.

[20]  M. Galli.  [Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[21]  D J Roe,et al.  Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. , 2000, The New England journal of medicine.

[22]  James K. Russell,et al.  Multicenter, Randomized, Controlled Trial of 150-J Biphasic Shocks Compared With 200- to 360-J Monophasic Shocks in the Resuscitation of Out-of-Hospital Cardiac Arrest Victims , 2000, Circulation.

[23]  A. Sowunmi,et al.  Patterns of Change in the Electrocardiogram after Halofantrine Treatment of Acute Uncomplicated Falciparum Malaria in Children , 2000 .

[24]  D M Roden,et al.  A common polymorphism associated with antibiotic-induced cardiac arrhythmia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[26]  B. Maron,et al.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[27]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[28]  M. Schwaiger,et al.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.

[29]  P. Poole‐Wilson,et al.  Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. , 2000, Circulation.

[30]  C Antzelevitch,et al.  The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. , 2000, European heart journal.

[31]  A. Marks,et al.  Cardiac intracellular calcium release channels: role in heart failure. , 2000, Circulation research.

[32]  W. Mckenna,et al.  Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. , 2000, The American journal of cardiology.

[33]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[34]  V. Roger,et al.  Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota. , 2000, Mayo Clinic proceedings.

[35]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[36]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[37]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[38]  F. Valagussa,et al.  The results of the GISSI-Prevenzione trial in the general framework of secondary prevention. , 2000, European heart journal.

[39]  S. Priori,et al.  Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias , 2000, Journal of cardiovascular electrophysiology.

[40]  P. Serruys,et al.  A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. , 2000, Journal of the American College of Cardiology.

[41]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[42]  J. Henney.  Infant Pneumococcal Vaccine , 2000 .

[43]  J. Henney.  Withdrawal of Troglitazone and Cisapride , 2000 .

[44]  J. Tamargo.  Drug-induced torsade de pointes: from molecular biology to bedside. , 2000, Japanese journal of pharmacology.

[45]  D. Corrado,et al.  Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. , 2000, Journal of the American College of Cardiology.

[46]  S. Connolly,et al.  Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. , 2000, Circulation.

[47]  A J Moss,et al.  Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. , 2000, Circulation.

[48]  A. Camm,et al.  Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). , 2000, Journal of the American College of Cardiology.

[49]  B. Maron,et al.  Preparticipation cardiovascular screening for US collegiate student-athletes. , 2000, JAMA.

[50]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[51]  T. Ikeda,et al.  Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. , 2000, Journal of the American College of Cardiology.

[52]  W. Edmunds,et al.  Health professionals do not understand mathematical models , 2000, BMJ : British Medical Journal.

[53]  S. Nuttall,et al.  beta Blockade after myocardial infarction. Beta blockers have key role in reducing morbidity and mortality after infarction. , 2000, BMJ.

[54]  S. Priori,et al.  Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2000, Circulation.

[55]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[56]  J. Towbin,et al.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.

[57]  M. Elizari,et al.  Morbidity and mortality following early administration of amiodarone in acute myocardial infarction , 2000 .

[58]  J. Goudevenos,et al.  Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course , 2000, Heart.

[59]  R. Cappato,et al.  A Randomized Comparison of Antiarrhythmic Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Cardiac Arrest: the Cardiac Arrest , 2000 .

[60]  G. Stone,et al.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. , 2000, The New England journal of medicine.

[61]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[62]  J. Larosa,et al.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. , 1999, JAMA.

[63]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[64]  J. Grisso,et al.  Violent injuries among women in an urban area. , 1999, The New England journal of medicine.

[65]  M. Eldar,et al.  Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. , 1999, Circulation.

[66]  R. Califf,et al.  Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial , 1999, The Lancet.

[67]  C von Birgelen,et al.  New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. , 1999, European heart journal.

[68]  Sonia S Anand,et al.  Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.

[69]  J. Kere,et al.  Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. , 1999, Journal of the American College of Cardiology.

[70]  J. Staessen,et al.  Overview of the outcome trials in older patients with isolated systolic hypertension , 1999, Journal of Human Hypertension.

[71]  M. Davies,et al.  A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy , 1999, Heart.

[72]  C Antzelevitch,et al.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. , 1999, Circulation research.

[73]  H. Watkins,et al.  Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.

[74]  M. Brodsky,et al.  Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. , 1999, Journal of the American College of Cardiology.

[75]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[76]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[77]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[78]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[79]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[80]  N G Pandian,et al.  Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). , 1999, Circulation.

[81]  H. Wellens,et al.  Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. , 1999, Journal of clinical epidemiology.

[82]  R A Levine,et al.  Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.

[83]  J. Bahr,et al.  Resuscitation in Europe: a tale of five European regions. , 1999, Resuscitation.

[84]  D. Darbar,et al.  QT dispersion is reduced after valve replacement in patients with aortic stenosis , 1999, Heart.

[85]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[86]  F. Morady,et al.  Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. , 1999, Journal of the American College of Cardiology.

[87]  M. Galinier,et al.  [Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?]. , 1999, Archives des maladies du coeur et des vaisseaux.

[88]  S. Hohnloser,et al.  Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. , 1999, Journal of the American College of Cardiology.

[89]  B. Maron,et al.  Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .

[90]  P. Tanière,et al.  Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases. , 1999, European heart journal.

[91]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[92]  M. Benn,et al.  QT dispersion in patients with arrhythmogenic right ventricular dysplasia. , 1999, European heart journal.

[93]  Competitive athletes with cardiovascular disease. , 1999 .

[94]  A. Camm,et al.  Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction , 1999, The Lancet.

[95]  P Ducimetière,et al.  Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.

[96]  J. Towbin,et al.  Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. , 1999, Circulation.

[97]  A. Angelini,et al.  Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. , 1999, The American journal of cardiology.

[98]  T. Raghunathan,et al.  Leisure-time physical activity and the risk of primary cardiac arrest. , 1999, Archives of internal medicine.

[99]  E Casiglia,et al.  High heart rate: a risk factor for cardiovascular death in elderly men. , 1999, Archives of internal medicine.

[100]  R. Virmani,et al.  Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.

[101]  M. Pfeffer,et al.  Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. , 1999, Journal of the American College of Cardiology.

[102]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[103]  R. Hauer,et al.  Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. , 1999, Circulation.

[104]  S. Priori,et al.  Low penetrance in the long-QT syndrome: clinical impact. , 1999, Circulation.

[105]  R. Hauer,et al.  Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management , 2022 .

[106]  R. Hauer,et al.  Genetic and molecular basis of cardiac arrhythmias : Impact on clinical management , 1999 .

[107]  R Yee,et al.  Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. , 1999, Circulation.

[108]  A. Pelliccia,et al.  Physiologic Left Ventricular Cavity Dilatation in Elite Athletes , 1999, Annals of Internal Medicine.

[109]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[110]  Paul J. Wang,et al.  Clinical Profile of Commotio Cordis: An Under Appreciated Cause of Sudden Death in the Young During Sports and Other Activities , 1999, Journal of cardiovascular electrophysiology.

[111]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[112]  M Borggrefe,et al.  Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[113]  G. Steinbeck,et al.  Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods. , 1999, Journal of the American College of Cardiology.

[114]  N Freemantle,et al.  beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.

[115]  N. Sheard.  Fish consumption and risk of sudden cardiac death. , 2009, Nutrition reviews.

[116]  ClausSchmitt,et al.  Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial Infarction , 1998 .

[117]  A. Kastrati,et al.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. , 1998, Circulation.

[118]  J. Bache.  European Resuscitation Council Guidelines for Resuscitation , 1998 .

[119]  R J Cohen,et al.  T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers , 1998, Journal of cardiovascular electrophysiology.

[120]  B. Maron,et al.  Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. , 1998, Journal of the American College of Cardiology.

[121]  B. Maron,et al.  Competitive athletes with cardiovascular disease--the case of Nicholas Knapp. , 1998, The New England journal of medicine.

[122]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[123]  H. Hachiya,et al.  Catheter Ablation of Ventricular Tachycardia in Patients with Right Ventricular Dysplasia: Identification of Target Sites by Entrainment Mapping Techniques , 1998, Pacing and clinical electrophysiology : PACE.

[124]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[125]  B. McCrindle,et al.  Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death. , 1998, The New England journal of medicine.

[126]  A. Moss,et al.  Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disea , 1998, Circulation.

[127]  S. Priori,et al.  Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. , 1998, The New England journal of medicine.

[128]  F. Triposkiadis,et al.  Hypertrophic cardiomyopathy in Greece: clinical course and outcome. , 1998, Chest.

[129]  Barry I. Maron.  Cardiovascular Risks to Young Persons on the Athletic Field , 1998, Annals of Internal Medicine.

[130]  W. Stevenson,et al.  Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. , 1998, Journal of the American College of Cardiology.

[131]  G. De Backer,et al.  Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. , 1998, Journal of the American College of Cardiology.

[132]  J. Burchenal,et al.  Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.

[133]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[134]  D. Ullyot,et al.  Minimally invasive coronary bypass: a dissenting opinion. , 1998, Circulation.

[135]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[136]  P. Paris,et al.  Use of automated external defibrillators by police officers for treatment of out-of-hospital cardiac arrest. , 1998, Annals of emergency medicine.

[137]  A. Brown,et al.  Blockade of HERG and Kv1.5 by ketoconazole. , 1998, The Journal of pharmacology and experimental therapeutics.

[138]  S. Ratel,et al.  Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia--an autopsy study of 20 forensic cases. , 1998, Journal of forensic sciences.

[139]  S. Hohnloser,et al.  Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. , 1998, Circulation.

[140]  G Mirra,et al.  An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis) , 1998, The New England journal of medicine.

[141]  B. Maron,et al.  Profile of preparticipation cardiovascular screening for high school athletes. , 1998, JAMA.

[142]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[143]  S. Priori,et al.  Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. , 1998, Circulation.

[144]  A I Mushlin,et al.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.

[145]  B. Maron,et al.  Implications of left ventricular remodeling in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[146]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[147]  C A Grimbergen,et al.  Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation. , 1998, Journal of the American College of Cardiology.

[148]  J. Gore,et al.  Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 1998, Journal of the American College of Cardiology.

[149]  R. Page,et al.  Defibrillation aboard a commercial aircraft. , 1998, Circulation.

[150]  B. Maron,et al.  Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.

[151]  M. Cotrufo,et al.  Increased QT dispersion and other repolarization abnormalities as a possible cause of electrical instability in isolated aortic stenosis. , 1998, International journal of cardiology.

[152]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[153]  A. Moss,et al.  Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. , 1998, Circulation.

[154]  J. Brugada,et al.  Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. , 1998, Circulation.

[155]  A. Hofman,et al.  QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. , 1998, Circulation.

[156]  G. Steinbeck,et al.  Can the MADIT results be applied to myocardial infarction patients at hospital discharge , 1998 .

[157]  B M Psaty,et al.  Family history as a risk factor for primary cardiac arrest. , 1998, Circulation.

[158]  R. Bordet,et al.  Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers , 1998, Fundamental & clinical pharmacology.

[159]  C. Furlanello,et al.  Cardiac Arrest and Sudden Death in Competitive Athletes with Arrhythmogenic Right Ventricular Dysplasia , 1998, Pacing and clinical electrophysiology : PACE.

[160]  J. Herlitz,et al.  Survival after cardiac arrest outside hospital in Sweden. Swedish Cardiac Arrest Registry. , 1998, Resuscitation.

[161]  A. Camm,et al.  Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). , 1998, European heart journal.

[162]  G. Stone,et al.  Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. , 1998, Journal of the American College of Cardiology.

[163]  A. Hofman,et al.  T-loop morphology as a marker of cardiac events in the elderly. , 1998, Journal of electrocardiology.

[164]  J. Burchenal,et al.  Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.

[165]  Bruce R. Brodie,et al.  Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction : In-hospital and 30-day results of the PAMI stent pilot trial , 1998 .

[166]  R. Gibbons,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. , 1998, JAMA.

[167]  C Ceriotti,et al.  Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia: principal component analysis of the ST-T waves. , 1997, Circulation.

[168]  Bigger Jt,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[169]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[170]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[171]  H. Wellens,et al.  Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. , 1997, Journal of the American College of Cardiology.

[172]  M. Janse,et al.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[173]  W. Mckenna,et al.  Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[174]  J S Geddes,et al.  An airline cardiac arrest program. , 1997, Circulation.

[175]  D. Corrado,et al.  Sudden death in young people with apparently isolated mitral valve prolapse. , 1997, Giornale italiano di cardiologia.

[176]  S. Peters.  Right ventricular cardiomyopathy: diffuse dilatation, focal dysplasia or biventricular disease. , 1997, International journal of cardiology.

[177]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[178]  E. Aliot,et al.  Prognostic value of thrombolysis, coronary artery patency, signal-averaged electrocardiography, left ventricular ejection fraction, and Holter electrocardiographic monitoring for life-threatening ventricular arrhythmias after a first acute myocardial infarction. , 1997, The American journal of cardiology.

[179]  H. Wellens,et al.  Arrhythmia Risk: Eiectrophysiological Studies and Monophasic Action Potentials , 1997, Pacing and clinical electrophysiology : PACE.

[180]  B. Phibbs,et al.  Torsade de pointes and low-dose oral haloperidol. , 1997, Archives of internal medicine.

[181]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[182]  J. Mason,et al.  Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. , 1997, Circulation.

[183]  Milton Packer,et al.  Safety and efficacy of carvedilol in severe heart failure , 1997 .

[184]  M. Viitasalo,et al.  QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. , 1997, Heart.

[185]  T. O. Cheng.  Myocardial bridging in a young patient with sudden death , 1997, Clinical cardiology.

[186]  W. Stevenson,et al.  Arrhythmias and sudden death in heart failure. , 1997, Japanese circulation journal.

[187]  David P Miller,et al.  Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention , 1997 .

[188]  David P Miller,et al.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. , 1997, JAMA.

[189]  Fesc,et al.  Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. , 1997, Journal of the American College of Cardiology.

[190]  D Kromhout,et al.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. , 1997, European heart journal.

[191]  G. Breithardt,et al.  Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. , 1997, Circulation.

[192]  D. Lane,et al.  Thrombomodulin gene mutations associated with myocardial infarction. , 1997, Circulation.

[193]  P. Heidenreich,et al.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.

[194]  J. Rey,et al.  Familial incidence of late ventricular potentials and electrocardiographic abnormalities in arrhythmogenic right ventricular dysplasia. , 1997, The American journal of cardiology.

[195]  D Kromhout,et al.  Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. , 1997, American journal of epidemiology.

[196]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[197]  S. Nasraway,et al.  Conduction Disturbances Associated with Administration of Butyrophenone Antipsychotics in the Critically Ill: A Review of the Literature , 1997, Pharmacotherapy.

[198]  J P Ornato,et al.  Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. A statement for healthcare professionals from the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Aus , 1997, Resuscitation.

[199]  A. Coats,et al.  Variation in mode of sudden cardiac death in patients with dilated cardiomyopathy. , 1997, European heart journal.

[200]  J. Ornato,et al.  Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital "Utstein style". A statement for health care professionals from the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Au , 1997, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[201]  J. Ornato,et al.  Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. , 1997, Circulation.

[202]  D. Chamberlain,et al.  Advisory statements of the International Liaison Committee on Resuscitation. , 1997, Circulation.

[203]  R. Califf,et al.  Clinical Guideline: Part II: Risk Stratification after Myocardial Infarction , 1997, Annals of Internal Medicine.

[204]  Richard P. Lewis,et al.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardio , 1997, Circulation.

[205]  B. Maron,et al.  Survival following blunt chest impact-induced cardiac arrest during sports activities in young athletes. , 1997, The American journal of cardiology.

[206]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[207]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[208]  G. Jones,et al.  Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. , 1997, Journal of forensic sciences.

[209]  C. Caspersen,et al.  Risk Factors for Sudden Coronary Death in the United States , 1997, Epidemiology.

[210]  H. Crijns,et al.  Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. , 1997, Heart.

[211]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[212]  K. Jamrozik,et al.  Risk factors for sudden unexpected cardiac death in Tasmanian men. , 1997, Australian and New Zealand journal of medicine.

[213]  J. Brugada,et al.  Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.

[214]  L Goldman,et al.  Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction , 1997 .

[215]  J. Cohn,et al.  Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. , 1997, Journal of cardiac failure.

[216]  M. Rich.  Risk for sudden cardiac death associated with marathon running. , 1997, Journal of the American College of Cardiology.

[217]  J. Bigger,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. , 1997, The New England journal of medicine.

[218]  D Kromhout,et al.  Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe , 1997 .

[219]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[220]  A. Kranidis,et al.  Torsades de pointes following radiofrequency catheter His ablation. , 1996, International journal of cardiology.

[221]  E. Raftery,et al.  The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol. , 1996, European heart journal.

[222]  O. K. Hansen,et al.  Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. , 1996, The Thoracic and cardiovascular surgeon.

[223]  C Antzelevitch,et al.  Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. , 1996, Journal of the American College of Cardiology.

[224]  C. Albert,et al.  Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. , 1996, The New England journal of medicine.

[225]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[226]  Roger D. White,et al.  High discharge survival rate after out-of-hospital ventricular fibrillation with rapid defibrillation by police and paramedics. , 1996, Annals of emergency medicine.

[227]  L. Tavazzi,et al.  The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Inf , 1996, European heart journal.

[228]  O. Frazier,et al.  Sudden cardiac death in cardiac transplant recipients. , 1996, Circulation.

[229]  P. Coumel,et al.  Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. , 1996, European heart journal.

[230]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[231]  E. Feskens,et al.  Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in elderly men (the Zutphen Elderly Study) , 1996, Journal of hypertension.

[232]  S. Chierchia,et al.  Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction. , 1996, Journal of the American College of Cardiology.

[233]  Salim Yusuf,et al.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials , 1996, BMJ.

[234]  P. Coumel,et al.  Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia. , 1996, Journal of the American College of Cardiology.

[235]  M. Goldman,et al.  Value of quantitative measurement of signal-averaged electrocardiographic variables in arrhythmogenic right ventricular dysplasia: correlation with echocardiographic right ventricular cavity dimensions. , 1996, Journal of the American College of Cardiology.

[236]  A. Hall,et al.  Mode of death in chronic heart failure. A request and proposition for more accurate classification. , 1996, European heart journal.

[237]  D. Atkins,et al.  Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.

[238]  P. Ridker,et al.  Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? , 1996, JAMA.

[239]  A. Maggioni,et al.  Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. , 1996, Circulation.

[240]  D. Wysowski,et al.  Cisapride and fatal arrhythmia. , 1996, The New England journal of medicine.

[241]  B. Maron,et al.  Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. , 1996, JAMA.

[242]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[243]  G. Breithardt,et al.  Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. , 1996, Circulation.

[244]  D. Zipes,et al.  Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. , 1996, Circulation.

[245]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[246]  M. Zack,et al.  Comparison of sudden and nonsudden coronary deaths in the United States. , 1996, Circulation.

[247]  P. Hanrath,et al.  Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. , 1996, Journal of the American College of Cardiology.

[248]  B. Komşuoğlu,et al.  Significance of QT dispersion on ventricular arrhythmias in mitral valve prolapse. , 1996, International journal of cardiology.

[249]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[250]  F. Lang,et al.  Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole , 1996, FEBS letters.

[251]  R. Liberthson,et al.  Sudden death from cardiac causes in children and young adults. , 1996, The New England journal of medicine.

[252]  R. Benton,et al.  Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram , 1996, Clinical pharmacology and therapeutics.

[253]  N. V. van Hemel,et al.  Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia. , 1996, European Heart Journal.

[254]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[255]  A. Weyman,et al.  Insights into the mechanism of incomplete mitral leaflet closure from an in vivo study , 1996 .

[256]  G. Breithardt,et al.  Implantable defibrillators are superior to d,I-sotalol for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease , 1996 .

[257]  M. Malik,et al.  Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. , 1996, Journal of the American College of Cardiology.

[258]  M. Schoenfeld,et al.  Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. , 1996, Circulation.

[259]  M. Malik,et al.  Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era. , 1996, The American journal of cardiology.

[260]  R. Woosley,et al.  Cardiac actions of antihistamines. , 1996, Annual review of pharmacology and toxicology.

[261]  D. Julian,et al.  Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 1996, European heart journal.

[262]  C. Rusconi,et al.  Prevalence of late potentials in adult aortic stenosis. , 1996, International journal of cardiology.

[263]  Y. Nakaya,et al.  [Idiopathic ventricular fibrillation]. , 1996, Ryoikibetsu shokogun shirizu.

[264]  D. Wilber.  Evaluation and treatment of nonsustained ventricular tachycardia. , 1996, Current Opinion in Cardiology.

[265]  James B. Young,et al.  Natural history, determinants, and clinical relevance of conduction abnormalities following orthotopic heart transplantation. , 1996, The American journal of cardiology.

[266]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[267]  A. Hermosillo,et al.  Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG. , 1995, Coronary artery disease.

[268]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[269]  B. Maron,et al.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.

[270]  J. Ornato,et al.  Public access defibrillation. A statement for healthcare professionals from the American Heart Association Task Force on Automatic External Defibrillation. , 1995, Circulation.

[271]  R. Virmani,et al.  Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. , 1995, Circulation.

[272]  M. Keating,et al.  Long QT syndrome associated with syndactyly identified in females. , 1995, The American journal of cardiology.

[273]  J. Kjekshus,et al.  -Blockers and Sudden Cardiac Death , 1995, Annals of Internal Medicine.

[274]  A. Gentile,et al.  Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). , 1995, American heart journal.

[275]  J. Rowley,et al.  Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death. , 1995, European heart journal.

[276]  H. Wellens,et al.  Aborted sudden death in the Wolff-Parkinson-White syndrome. , 1995, The American journal of cardiology.

[277]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[278]  F O Mueller,et al.  Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. , 1995, The New England journal of medicine.

[279]  A. Jonzon,et al.  Isolated congenital complete atrioventricular block in adult life. A prospective study. , 1995, Circulation.

[280]  H. Kennedy,et al.  Physician use of beta-adrenergic blocking therapy: a changing perspective. , 1995, Journal of the American College of Cardiology.

[281]  M. Niebauer,et al.  Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death. , 1995, American heart journal.

[282]  Richard P. Lewis,et al.  Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed , 1995, Journal of the American College of Cardiology.

[283]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[284]  R. Stables,et al.  Coronary stenting in the management of myocardial ischaemia caused by muscle bridging. , 1995, British heart journal.

[285]  P. Daleau,et al.  Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. , 1995, Circulation.

[286]  W. Mckenna,et al.  The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. , 1995, Circulation.

[287]  K. Yano,et al.  Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. , 1995, Circulation.

[288]  R. Devereux,et al.  Natural history of mitral valve prolapse. , 1995, The American journal of cardiology.

[289]  P. Kligfield.  Primary angioplasty in myocardial infarction. , 1995, British heart journal.

[290]  P. Podrid.  Amiodarone: Reevaluation of an Old Drug , 1995, Annals of Internal Medicine.

[291]  R. Cantu,et al.  Nontraumatic sports death in high school and college athletes. , 1995, Medicine and science in sports and exercise.

[292]  W. McKenna,et al.  Familial dilated cardiomyopathy in the United Kingdom. , 1995, British heart journal.

[293]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[294]  B. Maron,et al.  Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[295]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[296]  P. Macfarlane,et al.  Risk factors for sudden cardiac death in middle-aged British men. , 1995, Circulation.

[297]  P. Coumel,et al.  Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.

[298]  G Thiene,et al.  Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. , 1995, Journal of the American College of Cardiology.

[299]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[300]  J. Cohn,et al.  Interobserver discordance in the classification of mechanisms of death in studies of heart failure. , 1995, Journal of cardiac failure.

[301]  P. Mabo,et al.  Characteristics and outcome in arrhythmogenic right ventricular dysplasia. , 1995, The American journal of cardiology.

[302]  E. Antman.  Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. , 1995, The American journal of cardiology.

[303]  S. Yusuf,et al.  Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.

[304]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[305]  R. Tieleman,et al.  Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. , 1995, British heart journal.

[306]  S. Coughlin,et al.  Idiopathic dilated cardiomyopathy. , 1994, The New England journal of medicine.

[307]  K. Bailey,et al.  Sudden unexpected nontraumatic deaths in young adults: A 30-year population-based study , 1991 .

[308]  S. Peters.  Left ventricular impairment in arrhythmogenic right ventricular dysplasia: what we can learn from angiography. , 1995, Cardiology.

[309]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[310]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.

[311]  K. Cherian,et al.  Modified supra-arterial myotomy for intermittent coronary obstruction by myocardial bridges. , 1995, Scandinavian Journal of Thoracic and Cardiovascular Surgery.

[312]  W. Crumb,et al.  Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. , 1995, Molecular pharmacology.

[313]  L A Moyé,et al.  The cardiac arrhythmia suppression trial. Casting suppression in a different light. , 1995, Circulation.

[314]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[315]  G. Sinagra,et al.  Changing mortality in dilated cardiomyopathy , 1994 .

[316]  C. Cannon,et al.  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. , 1994, Journal of the American College of Cardiology.

[317]  R. Saumarez,et al.  The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. , 1994, Circulation.

[318]  C. Autore,et al.  Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.

[319]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[320]  A. Camm,et al.  Ambulatory Assessment of the QT Interval in Patients with Hypertrophic Cardiomyopathy: Risk Stratification and Effect of Low Dose Amiodarone , 1994, Pacing and clinical electrophysiology : PACE.

[321]  B. Maron,et al.  Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse , 1994 .

[322]  B. Maron,et al.  26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .

[323]  S. Hohnloser,et al.  Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. , 1994, Circulation.

[324]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[325]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[326]  E. Topol,et al.  Effects of Thrombolytic Therapy Administered 6 to 24 Hours After Myocardial Infarction on the Signal‐Averaged ECG: Results of a Multicenter Randomized Trial , 1994, Circulation.

[327]  D Kromhout,et al.  Association Between QT Interval and Coronary Heart Disease in Middle‐aged and Elderly Men: The Zutphen Study , 1994, Circulation.

[328]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[329]  J. Dartigues,et al.  [Ventricular fibrillation in Wolff-Parkinson-White syndrome. Predictive factors]. , 1994, Archives des maladies du coeur et des vaisseaux.

[330]  J. Blanc,et al.  [Permanent cardiac stimulation after aortic valve replacement: incidence, predictive factors and long-term prognosis]. , 1994, Archives des maladies du coeur et des vaisseaux.

[331]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[332]  L. Fauchier,et al.  Ventricular Arrhythmia Factors in Mitral Valve Prolapse , 1994, Pacing and clinical electrophysiology : PACE.

[333]  G Thiene,et al.  The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. , 1994, Human molecular genetics.

[334]  B. Diquet,et al.  The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. , 1994, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[335]  A. Moss,et al.  T wave alternans in idiopathic long QT syndrome. , 1994, Journal of the American College of Cardiology.

[336]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.

[337]  S. Fletcher,et al.  Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) , 1994, The Lancet.

[338]  H. Scheld,et al.  Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. , 1994, American heart journal.

[339]  S. Priori,et al.  Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. , 1994, Circulation.

[340]  B. Maron,et al.  Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. , 1994, The American journal of cardiology.

[341]  L. Wilkins.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .

[342]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[343]  C. Pratt,et al.  Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. , 1994, The American journal of cardiology.

[344]  Fibrinolytic Therapy Trialists' Collaborative Group.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.

[345]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[346]  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. , 1994, BMJ.

[347]  M. Brown.  Beta-blockers in heart failure. , 1994, Lancet.

[348]  Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. , 1994, Lancet.

[349]  B. Maron,et al.  26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. , 1994, Medicine and science in sports and exercise.

[350]  A. di Lenarda,et al.  Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. , 1994, British heart journal.

[351]  L. Wilkins,et al.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.

[352]  GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. , 1994, Lancet.

[353]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[354]  M. Desai,et al.  Management of hypertrophic cardiomyopathy. , 1993, Heart disease and stroke : a journal for primary care physicians.

[355]  D. Di Maio,et al.  Incidence of Coronary Thrombosis in Sudden Death due to Coronary Artery Disease , 1993, The American journal of forensic medicine and pathology.

[356]  M. Alam,et al.  The Role of Transesophageal Echocardiography in Identifying Anomalous Coronary Arteries , 1993, Circulation.

[357]  A. Camm,et al.  The European Myocardial Infarct Amiodarone Trial (EMIAT) , 1993 .

[358]  H. Greene.  The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. , 1993, The American journal of cardiology.

[359]  D. Baudendistel.  Heart Disease A Textbook of Cardiovascular Medicine , 1993 .

[360]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[361]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[362]  U. Goldbourt,et al.  Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. SPRINT Study Group. , 1993, The American journal of cardiology.

[363]  Philip Sager,et al.  Identification of Reentry Circuit Sites During Catheter Mapping and Radiofrequency Ablation of Ventricular Tachycardia Late After Myocardial Infarction , 1993, Circulation.

[364]  M. Frediani,et al.  QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant. , 1993, American heart journal.

[365]  P. Coumel,et al.  Late potentials in arrhythmogenic right ventricular dysplasia. Prevalence, diagnostic and prognostic values. , 1993, European heart journal.

[366]  V. Dilsizian,et al.  Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[367]  J. Mason.  A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. , 1993, The New England journal of medicine.

[368]  B. Maron.  Sudden death in young athletes. Lessons from the Hank Gathers affair. , 1993, The New England journal of medicine.

[369]  P. Macfarlane,et al.  Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. , 1993, British heart journal.

[370]  N. Wenger,et al.  Risk stratification after myocardial infarction. , 1993, Current opinion in cardiology.

[371]  J R Roelandt,et al.  Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. , 1993, Circulation.

[372]  T. Butler,et al.  QT prolongation and sudden cardiac death in patients with alcoholic liver disease , 1993, The Lancet.

[373]  S. Viskin,et al.  Idiopathic Ventricular Tachycardia and Fibrillation , 1993, Journal of cardiovascular electrophysiology.

[374]  P. Fornés,et al.  Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis. , 1993, Journal of forensic sciences.

[375]  A. Adgey,et al.  Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. , 1993, Journal of the American College of Cardiology.

[376]  D. Kyle,et al.  Cardiac effects of antimalarial treatment with halofantrine , 1993, The Lancet.

[377]  B. Brembilla-Perrot,et al.  Electrophysiological characteristics of asymptomatic Wolff-Parkinson-White syndrome. , 1993, European heart journal.

[378]  George A. Johnson,et al.  Implantable transvenous cardioverter-defibrillators. , 1993, Circulation.

[379]  P. Held.  Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. , 1993, The American journal of cardiology.

[380]  N. White,et al.  A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. , 1993, British journal of clinical pharmacology.

[381]  J. Vohra,et al.  Malignant Ventricular Arrhythmias in Patients with Mitral Valve Prolapse and Mild Mitral Regurgitation , 1993, Pacing and clinical electrophysiology : PACE.

[382]  K. Bailey,et al.  A Population Study of the Natural History of Wolff‐Parkinson‐White Syndrome in Olmsted Count, Minnesota, 1953‐1989 , 1993, Circulation.

[383]  J. Langberg,et al.  Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Coronary Artery Disease , 1993, Circulation.

[384]  L. Tavazzi,et al.  Prevalence and Prognostic Significance of Ventricular Arrhythmias After Acute Myocardial Infarction in the Fibrinolytic Era GISSI‐2 Results , 1993, Circulation.

[385]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[386]  H. Greene.  Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. , 1993, The American journal of cardiology.

[387]  K. Rhodes,et al.  Incidence of cardiac arrest: a neglected factor in evaluating survival rates. , 1993, Annals of emergency medicine.

[388]  W. Stevenson,et al.  Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. , 1993, Journal of the American College of Cardiology.

[389]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[390]  S. Yusuf,et al.  Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. , 1992, Journal of the American College of Cardiology.

[391]  D. Wyse,et al.  Precordial QT Interval Dispersion as a Marker of Torsade de Pointes: Disparate Effects of Class Ta Antiarrhythmic Drugs and Amiodarone , 1992, Circulation.

[392]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[393]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[394]  R. Woosley,et al.  Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin , 1992, Clinical pharmacology and therapeutics.

[395]  A. Jacobs,et al.  Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. , 1992, Journal of the American College of Cardiology.

[396]  S. Epstein,et al.  Prognostic Determinants in Hypertrophic Cardiomyopathy: Prospective Evaluation of a Therapeutic Strategy Based on Clinical, Holter, Hemodynamic, and Electrophysiological Findings , 1992, Circulation.

[397]  G. Friman,et al.  Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer , 1992, The Lancet.

[398]  E. Bodor,et al.  Congenital complete heart block associated with QT prolongation. , 1992, European heart journal.

[399]  F. Mosteller,et al.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.

[400]  G. Breithardt,et al.  Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.

[401]  A. Camm,et al.  Effect of thrombolytic therapy on the predictive value of signal-averaged electrocardiography after acute myocardial infarction. , 1992, The American journal of cardiology.

[402]  S. Viskin,et al.  Anomalous origin of the left coronary artery from the pulmonary artery: report of an adult with ventricular fibrillation as the presenting symptom. , 1992, American heart journal.

[403]  H. Tunstall-Pedoe,et al.  Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results. , 1992, BMJ.

[404]  S. Colan,et al.  Diagnosis of anomalous left coronary artery by Doppler color flow mapping: distinction from other causes of dilated cardiomyopathy. , 1992, Journal of the American College of Cardiology.

[405]  J. Langberg,et al.  Survival after implantation of the cardioverter defibrillator. , 1992, The American journal of cardiology.

[406]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[407]  ISIS-1 Collaborative Group.  ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction , 1992, The Lancet.

[408]  T. Meinertz,et al.  Prevalence, Circumstances, Mechanisms, and Risk Stratification of Sudden Cardiac Death in Unipolar Single‐Chamber Ventricular Pacing , 1992, Circulation.

[409]  A. Tajik,et al.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.

[410]  A. Castellanos,et al.  Sudden cardiac death. Structure, function, and time-dependence of risk. , 1992, Circulation.

[411]  R. O'rourke.  Role of myocardial revascularization in sudden cardiac death. , 1992, Circulation.

[412]  W. Kannel,et al.  Long- and short-term risk of sudden coronary death. , 1992, Circulation.

[413]  J. Fleiss,et al.  Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. , 1992, The American journal of cardiology.

[414]  C W Otto,et al.  A study of chest compression rates during cardiopulmonary resuscitation in humans. The importance of rate-directed chest compressions. , 1992, Archives of internal medicine.

[415]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[416]  R. Califf,et al.  Thrombolytic therapy for acute myocardial infarction. A review . , 1992, Drugs.

[417]  W. Kannel.  Left ventricular hypertrophy as a risk factor: the Framingham experience , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[418]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[419]  R. Virmani,et al.  Right ventricular dysplasia associated with sudden death in young adults. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[420]  M. Beahrs,et al.  Thrombolytic therapy for acute myocardial infarction. , 1991, Postgraduate medicine.

[421]  Lippincott Williams Wilkins,et al.  The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1991, Circulation.

[422]  Y. Pawitan,et al.  Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial , 1991 .

[423]  A. Moss,et al.  Efficacy of Permanent Pacing in the Management of High‐Risk Patients With Long QT Syndrome , 1991, Circulation.

[424]  J. Vandenbroucke,et al.  QT Interval Prolongation Predicts Cardiovascular Mortality in an Apparently Healthy Population , 1991, Circulation.

[425]  A. Camm,et al.  Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. , 1991, Journal of the American College of Cardiology.

[426]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[427]  British Pacing,et al.  Recommendations for pacemaker prescription for symptomatic bradycardia , 1991 .

[428]  C. Hengstenberg,et al.  Immune response to the endothelium in myocarditis, dilated cardiomyopathy and rejection after heart transplantation. , 1991, European heart journal.

[429]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[430]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[431]  A. Moss,et al.  Left Cardiac Sympathetic Denervation in the Therapy of Congenital Long QT Syndrome: A Worldwide Report , 1991, Circulation.

[432]  D. Webb,et al.  Abnormal Vascular Responses to Supine Exercise in Hypertrophic Cardiomyopathy , 1991, Circulation.

[433]  T. Guarnieri,et al.  Predictors of First Discharge and Subsequent Survival in Patients With Automatic Implantable Cardioverter‐Defibrillators , 1991, Circulation.

[434]  H. Vapaatalo,et al.  A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland , 1991, Acta psychiatrica Scandinavica.

[435]  C. Furberg,et al.  Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. , 1991, The American journal of cardiology.

[436]  Jan Pool,et al.  QTc Prolongation Measured by Standard 12‐Lead Electrocardiography Is an Independent Risk Factor for Sudden Death Due to Cardiac Arrest , 1991, Circulation.

[437]  R. Myerburg,et al.  Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease. , 1991, The American journal of cardiology.

[438]  R. Loire,et al.  [Myocardial bridging on the left anterior descending coronary artery and sudden death. Apropos of 19 cases with autopsy]. , 1991, Archives des maladies du coeur et des vaisseaux.

[439]  B. Brembilla-Perrot,et al.  Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. , 1991, American heart journal.

[440]  J Barrett,et al.  Outcome of CPR in a large metropolitan area--where are the survivors? , 1991, Annals of emergency medicine.

[441]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[442]  K. Byth,et al.  What Is the Best Predictor of Spontaneous Ventricular Tachycardia and Sudden Death After Myocardial Infarction? , 1991, Circulation.

[443]  J. Meyer,et al.  Sudden cardiac death while wearing a Holter monitor. , 1991, American Journal of Cardiology.

[444]  P. Coumel,et al.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1991, European heart journal.

[445]  J E Smialek,et al.  Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.

[446]  R. Califf,et al.  Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy , 1991 .

[447]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[448]  K. Lee,et al.  Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group. , 1991, The American journal of cardiology.

[449]  Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group. , 1991, British heart journal.

[450]  H. Trappe,et al.  Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome. , 1991, Journal of the American College of Cardiology.

[451]  Y. Pawitan,et al.  Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. , 1991, American Journal of Cardiology.

[452]  Richard P. Lewis,et al.  ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Clinical Application of Echocard , 1990, Circulation.

[453]  M. Pfisterer,et al.  Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) , 1990, Journal of the American College of Cardiology.

[454]  W. Kannel,et al.  Epidemiology of sudden coronary death: population at risk. , 1990, The Canadian journal of cardiology.

[455]  P. Gillette,et al.  Clinical and electrophysiological characteristics of ventricular tachycardia in children with normal hearts. , 1990, American heart journal.

[456]  P Théroux,et al.  A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. , 1990, Circulation.

[457]  M. Frenneaux,et al.  Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. , 1990, Circulation.

[458]  J. Owens,et al.  Features of "near-death experience" in relation to whether or not patients were near death , 1990, The Lancet.

[459]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[460]  G. Klein,et al.  Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. , 1990, Circulation.

[461]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[462]  R. Fogoros,et al.  Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. , 1990, Journal of the American College of Cardiology.

[463]  D. Wilber,et al.  Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. , 1990, Circulation.

[464]  P Smith,et al.  The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.

[465]  D. Spodick,et al.  The incidence and prognosis of unrecognized myocardial infarction. , 1990, Archives of internal medicine.

[466]  Control of multiform ventricular tachycardia by propranolol in a child with no identifiable cardiac disease and sudden death. , 1990, American heart journal.

[467]  J. Kjekshus.  Arrhythmias and mortality in congestive heart failure. , 1990, The American journal of cardiology.

[468]  A. Skene,et al.  Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study , 1990, The Lancet.

[469]  P. Poole‐Wilson.  Idiopathic dilated cardiomyopathy. , 1990, BMJ.

[470]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[471]  A. Keogh,et al.  Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. , 1990, The American journal of cardiology.

[472]  K. Bailey,et al.  The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. , 1990, Journal of the American College of Cardiology.

[473]  R. Hariman,et al.  The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. , 1990, Journal of the American College of Cardiology.

[474]  W. Mckenna,et al.  Good prognosis for dilated cardiomyopathy without severe heart failure or arrhythmia. , 1990, The Quarterly journal of medicine.

[475]  J. Mcanulty,et al.  Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. , 1990, The American journal of cardiology.

[476]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[477]  Nie Fe.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) , 1990 .

[478]  Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. AIMS Trial Study Group. , 1990, Lancet.

[479]  C. Wooley,et al.  Mitral valve prolapse: cardiac arrest with long-term survival. , 1990, International journal of cardiology.

[480]  W. Kochman,et al.  [Myocardial bridging as an isolated angiographic change in the anterior descending branch of the left coronary artery]. , 1990, Kardiologia polska.

[481]  J. F. Hansen,et al.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) , 1990, The American journal of cardiology.

[482]  L. Clark.  Anatomic substrate differences between black and white victims of sudden cardiac death: Hypertension, coronary artery disease, or both? , 1989, Clinical cardiology.

[483]  J. Johns,et al.  Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. , 1989, Journal of the American College of Cardiology.

[484]  E. Walsh,et al.  Congenital complete heart block in patients without anatomic cardiac defects. , 1989, American heart journal.

[485]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[486]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[487]  G. Kay,et al.  Rate-modulated cardiac pacing based on transthoracic impedance measurements of minute ventilation: correlation with exercise gas exchange. , 1989, Journal of the American College of Cardiology.

[488]  M. Lesch,et al.  Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. , 1989, Annals of internal medicine.

[489]  R. Lazzara.  Amiodarone and torsade de pointes. , 1989, Annals of internal medicine.

[490]  P. Coumel,et al.  Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia. , 1989, European heart journal.

[491]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[492]  J. Gallagher,et al.  Long-term follow-up in patients with arrhythmogenic right ventricular disease. , 1989, European heart journal.

[493]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[494]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[495]  P. Brugada,et al.  Nonischemic sustained ventricular tachycardia: clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia. , 1989, Journal of the American College of Cardiology.

[496]  R. Bestetti,et al.  Fatal outcome associated with autopsy proven myocardial bridging of the left anterior descending coronary artery. , 1989, European heart journal.

[497]  R. Winkle,et al.  Long-term outcome with the automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.

[498]  B. Maron,et al.  Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.

[499]  N. V. van Hemel,et al.  Left ventricular segmental wall motion score as a criterion for selecting patients for direct surgery in the treatment of postinfarction ventricular tachycardia. , 1989, European heart journal.

[500]  P. Stulz,et al.  Sudden cardiac death after aortic valve surgery: Incidence and concomitant factors , 1989, Clinical cardiology.

[501]  R. Gillum,et al.  Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.

[502]  M. Z. Berisso,et al.  Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. , 1989, The New England journal of medicine.

[503]  R. Kronmal,et al.  Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study. , 1989, Journal of the American College of Cardiology.

[504]  A. Angelini,et al.  Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. , 1989, European heart journal.

[505]  P. Angelini.  Normal and anomalous coronary arteries: definitions and classification. , 1989, American heart journal.

[506]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[507]  P. Lewi,et al.  Pre-CPR conditions and the final outcome of CPR. The Cerebral Resuscitation Study Group. , 1989, Resuscitation.

[508]  J F Leclercq,et al.  Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.

[509]  F. Pelliccia,et al.  Predictors of sudden death in idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[510]  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.

[511]  A. Reunanen,et al.  Risk factors for sudden and non-sudden coronary death. , 2009, Acta medica Scandinavica.

[512]  M. Davies,et al.  Community study of the causes of "natural" sudden death. , 1988, BMJ.

[513]  W. Roberts,et al.  Anomalous origin of either the right or left main coronary artery from the aorta without coursing of the anomalistically arising artery between aorta and pulmonary trunk. , 1988, The American journal of cardiology.

[514]  A. Tonkin,et al.  Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope. , 1988, Australian and New Zealand journal of medicine.

[515]  S. Hohnloser,et al.  Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. , 1988, American heart journal.

[516]  G. Thiene,et al.  Familial occurrence of right ventricular dysplasia: a study involving nine families. , 1988, Journal of the American College of Cardiology.

[517]  R. Collins,et al.  Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.

[518]  P. Schwartz,et al.  Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. , 1988, Circulation.

[519]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[520]  E F Cook,et al.  Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. , 1988, The New England journal of medicine.

[521]  J Brandt,et al.  Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. , 1988, American heart journal.

[522]  R. Collins,et al.  EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS , 1988, The Lancet.

[523]  C. Gohlke-Bärwolf,et al.  Influence of aortic valve replacement on sudden death in patients with pure aortic stenosis. , 1988, European heart journal.

[524]  D. Horstkotte,et al.  The natural history of aortic valve stenosis. , 1988, European heart journal.

[525]  J. Matloff,et al.  Reduction in sudden late death by concomitant revascularization with aortic valve replacement. , 1988, The Journal of thoracic and cardiovascular surgery.

[526]  R. D'Agostino,et al.  Hypertension, Antihypertensive Treatment, and Sudden Coronary Death The Framingham Study , 1988, Hypertension.

[527]  K. Kuck,et al.  Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. , 1988, European heart journal.

[528]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[529]  H. Schröder,et al.  Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation. , 1988, European heart journal.

[530]  The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group. , 1988, European heart journal.

[531]  J. Fleiss,et al.  Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. , 1988, The American journal of cardiology.

[532]  R. Franklin,et al.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[533]  J. Mcanulty,et al.  Idiopathic Dilated Cardiomyopathy : Role of Programmed Electrical Stimulation and Holter Monitoring in Predicting Those at Risk of Sudden Death , 1988 .

[534]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[535]  R. Fogoros,et al.  The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. , 1987, Annals of internal medicine.

[536]  S. Olsson,et al.  A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. , 1987, British heart journal.

[537]  S. Menahem,et al.  Anomalous left coronary artery from the pulmonary artery: a 15 year sample. , 1987, British heart journal.

[538]  H. Schmidinger,et al.  Sudden death during ambulatory Holter monitoring. , 1987, International journal of cardiology.

[539]  R. Beaglehole,et al.  Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. , 1987, American journal of epidemiology.

[540]  J. Mason,et al.  Sudden death in idiopathic dilated cardiomyopathy. , 1987, Annals of internal medicine.

[541]  R. Bonow,et al.  Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. , 1987, The American journal of cardiology.

[542]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[543]  M. Josephson,et al.  Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. , 1987, Circulation.

[544]  R. Jeremy,et al.  Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. , 1987, Journal of the American College of Cardiology.

[545]  B. Gersh,et al.  Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. , 1987, The American journal of cardiology.

[546]  T. Peter,et al.  QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. , 1987, The American journal of cardiology.

[547]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[548]  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1987, The New England journal of medicine.

[549]  H. Lithell,et al.  Alcohol intemperance and social disability as risk factors for different causes of death. , 2009, Acta Medica Scandinavica.

[550]  G. Lamas,et al.  A simplified method to predict occurrence of complete heart block during acute myocardial infarction. , 1987, The American journal of cardiology.

[551]  R. Virmani,et al.  Sudden cardiac death in Air Force recruits. A 20-year review. , 1986, JAMA.

[552]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[553]  J. Bachman,et al.  A study of out-of-hospital cardiac arrests in northeastern Minnesota. , 1986, JAMA.

[554]  H. Shimada,et al.  The significance of myocardial bridge upon atherosclerosis in the left anterior descending coronary artery , 1986, The Journal of pathology.

[555]  A. Castellanos,et al.  Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[556]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[557]  R. Estabrook,et al.  Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents. , 1986, Biochemical pharmacology.

[558]  L. Cobb,et al.  Smoking as a risk factor for recurrence of sudden cardiac arrest. , 1986, The New England journal of medicine.

[559]  R. Bents,et al.  [Clinical course of 470 patients with mitral valve prolapse]. , 1986, Zeitschrift fur Kardiologie.

[560]  J. Salerno.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). , 1986, Lancet.

[561]  W. Roberts,et al.  Causes of sudden death in competitive athletes. , 1986, Journal of the American College of Cardiology.

[562]  A. Tajik,et al.  Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. , 1985, The New England journal of medicine.

[563]  L. Griffith,et al.  Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. , 1985, The American journal of cardiology.

[564]  E. Blackstone,et al.  Death and other time-related events after valve replacement. , 1985, Circulation.

[565]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[566]  W. Kannel,et al.  Sudden death: lessons from subsets in population studies. , 1985, Journal of the American College of Cardiology.

[567]  D. Veale,et al.  Survival in second degree atrioventricular block. , 1985, British heart journal.

[568]  D. Harrison,et al.  Atrioventricular Conduction Abnormalities in Patients Undergoing Isolated Aortic or Mitral Valve Replacement , 1985, Pacing and clinical electrophysiology : PACE.

[569]  C. Oakley,et al.  Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.

[570]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[571]  P. Schwartz,et al.  Idiopathic long QT syndrome: progress and questions. , 1985, American heart journal.

[572]  J. Mason,et al.  Electrophysiologic testing in patients with the long QT syndrome. , 1985, Circulation.

[573]  W. Kannel,et al.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.

[574]  D. Siscovick,et al.  The incidence of primary cardiac arrest during vigorous exercise. , 1984, The New England journal of medicine.

[575]  J. Deanfield,et al.  Hypertrophic cardiomyopathy: an important cause of sudden death. , 1984, Archives of disease in childhood.

[576]  A Bhandari,et al.  Electrophysiologic testing in bundle branch block and unexplained syncope. , 1984, The American journal of cardiology.

[577]  J. Young,et al.  Torsade de Pointe. Malignant cardiac arrhythmia induced by amantadine poisoning. , 1984, The American journal of medicine.

[578]  M. Josephson,et al.  Cardiac arrest recorded on ambulatory electrocardiograms. , 1984, The American journal of cardiology.

[579]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[580]  C. Furberg,et al.  THERAPY AND PREVENTION , 2005 .

[581]  T. Meinertz,et al.  Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1984, The American journal of cardiology.

[582]  J. Lubsen,et al.  Sudden death during longterm ambulatory monitoring. , 1984, European heart journal.

[583]  I. Panidis,et al.  Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. , 1983, Journal of the American College of Cardiology.

[584]  M. Josephson,et al.  Electrophysiologic evaluation of syncope in patients with bifascicular block. , 1983, American heart journal.

[585]  W. Kannel,et al.  Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. , 1983, American heart journal.

[586]  P. Clark.  Non-traumatic death in joggers , 1983 .

[587]  N. White,et al.  Quinine and Quinidine: A Comparison of EKG Effects During the Treatment of Malaria , 1983, Journal of cardiovascular pharmacology.

[588]  L. Gram,et al.  Beta-blockade after myocardial infarction , 1977, Ugeskrift for laeger.

[589]  R. Peters,et al.  Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. , 1982, The American journal of cardiology.

[590]  B. Lucchesi,et al.  Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. , 1982, The American journal of cardiology.

[591]  S. Rahimtoola,et al.  Natural history of "high-risk" bundle-branch block: final report of a prospective study. , 1982, The New England journal of medicine.

[592]  G. Nikolić,et al.  Sudden Death Recorded During Holter Monitoring , 1982, Circulation.

[593]  R. Virmani,et al.  Nontraumatic death in joggers. A series of 30 patients at autopsy. , 1982, The American journal of medicine.

[594]  W. Roberts,et al.  Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. , 1982, Circulation.

[595]  W Q Sturner,et al.  Incidence of death during jogging in Rhode Island from 1975 through 1980. , 1982, JAMA.

[596]  A. Castellanos,et al.  Survivors of prehospital cardiac arrest. , 1982, JAMA.

[597]  L E Hinkle,et al.  Clinical Classification of Cardiac Deaths , 1982, Circulation.

[598]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[599]  A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. , 1982, The New England journal of medicine.

[600]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[601]  B. Maron,et al.  Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. , 1981, The American journal of cardiology.

[602]  W. Mckenna,et al.  Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. , 1981, British heart journal.

[603]  S. Swiryn,et al.  Natural History of Chronic Second‐degree Atrioventricular Nodal Block , 1981, Circulation.

[604]  W. Mckenna,et al.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. , 1981, The American journal of cardiology.

[605]  V. Fuster,et al.  The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.

[606]  M. Herman,et al.  QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration. , 1981, The Mount Sinai journal of medicine, New York.

[607]  C. Fisch,et al.  Bundle branch block and sudden death. , 1980, Progress in cardiovascular diseases.

[608]  V L Gott,et al.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.

[609]  J. Gowers,et al.  Survival in sinoatrial disorder (sick-sinus syndrome). , 1980, British medical journal.

[610]  M. Rosen,et al.  Effects of Tetrodotoxin, Lidocaine, Verapamil, and AHR‐2666 on Ouabain‐ Induced Delayed Afterdepolarizations in Canine Purkinje Fibers , 1980, Circulation research.

[611]  H. Wellens,et al.  Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. , 1980, The American journal of cardiology.

[612]  S. Swiryn,et al.  Significance of Block Distal to the His Bundle Induced by Atrial Pacing in Patients with Chronic Bifascicular Block , 1979, Circulation.

[613]  R. Peters,et al.  Prophylactic permanent pacemakers for patients with chronic bundle branch block. , 1979, The American journal of medicine.

[614]  R. Dinsmore,et al.  Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management. , 1979, Circulation.

[615]  A. Tonkin,et al.  Intermittent atrioventricular block: procainamide administration as a provocative test. , 1978, Australian and New Zealand journal of medicine.

[616]  Chung Ek,et al.  Ventricular fibrillation in Wolff-Parkinson-White syndrome, type A. , 1978 .

[617]  K. Rosen,et al.  Significance of left axis deviation in patients with chronic left bundle branch block. , 1978, The American journal of cardiology.

[618]  A. Iskandrian,et al.  Anomalous Aortic Origin of Coronary Arteries , 1978, Circulation.

[619]  M. Rubenfire,et al.  The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion. , 1978, Circulation.

[620]  M. Rubenfire,et al.  The Clinical Significance of Bundle Branch Block Complicating Acute Myocardial Infarction , 1978, Circulation.

[621]  L. Vertesi.  The paramedic ambulance: a Canadian experience. , 1978, Canadian Medical Association journal.

[622]  J. Burton,et al.  QT Interval Prolongation as Predictor of Sudden Death in Patients with Myocardial Infarction , 1978 .

[623]  P. Coumel.  Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children : report of four cases , 1978 .

[624]  P. Denes,et al.  Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification. , 1977, Annals of internal medicine.

[625]  P. Denes,et al.  Sudden death in patients with chronic bifascicular block. , 1977, Archives of internal medicine.

[626]  R. Sutton,et al.  Long-term prognosis after acute anterior infarction with atrioventricular block. , 1977, British heart journal.

[627]  Å. Swahn,et al.  Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients. , 2009, Acta medica Scandinavica.

[628]  R. Campbell,et al.  Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk group. , 1976, British heart journal.

[629]  A Malliani,et al.  Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. , 1975, American heart journal.

[630]  M. Cheitlin,et al.  Sudden Death as a Complication of Anomalous Left Coronary Origin From the Anterior Sinus of Valsalva: A Not‐So‐Minor Congenital Anomaly , 1974, Circulation.

[631]  S. Carveth,et al.  Emergency Medical Care System: Lincoln (Neb) Mobile Heart Team , 1974 .

[632]  P. Denes,et al.  The Significance of Second Degree Atrioventricular Block and Bundle Branch Block: Observations Regarding Site and Type of Block , 1974, Circulation.

[633]  N. Benowitz,et al.  Electrophysiologic Effects of Procaine Amide in Patients with Intraventricular Conduction Delay , 1974, Circulation.

[634]  Standards for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). , 1974, JAMA.

[635]  S. Carveth,et al.  Proceedings: Emergency medical care system. Lincoln (Beb) mobile heart team. , 1974, Archives of surgery.

[636]  S. Weinberg,et al.  The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. , 1972, The American journal of cardiology.

[637]  M. A. Engle,et al.  Congenital complete heart block: an international study of the natural history. , 1972, Cardiovascular clinics.

[638]  Johansson Bw.  Complete heart block. A clinical, hemodynamic and pharmacological study in patients with and without an artificial pacemaker. , 1966 .

[639]  B. Johansson.  Complete heart block. A clinical, hemodynamic and pharmacological study in patients with and without an artificial pacemaker. , 1966, Acta medica Scandinavica. Supplementum.

[640]  B. Carabello,et al.  Aortic stenosis , 2018, Rapid Cardiac Care.

[641]  M. Campbell.  COMPLETE HEART BLOCK , 1944, British heart journal.